Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Abstract Text:

Takashi Kijima,Mayumi Suzuki,Kayo Ueda,Seigo Minami,Yoshito Takeda,Sho Goya,Hiroto Matsuoka,Toru Kumagai,Mitsuhiro Yoshida,Tadashi Osaki,Isao Tachibana,Soichiro Yokota,Ichiro Kawase,Takashi Kijima,Mayumi Suzuki,Kayo Ueda,Seigo Minami,Yoshito Takeda,Sho Goya,Hiroto Matsuoka,Toru Kumagai,Mitsuhiro Yoshida,Tadashi Osaki,Isao Tachibana,Soichiro Yokota,Ichiro Kawase,

The tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) gefitinib has beneficial effect in some patients with refractory advanced non-small cell lung cancer (NSCLC). However, the majority of responders eventually develop acquired resistance during the course of prolonged continuous treatment. Here we present a case of 76-year-old Japanese female, who had never smoked, with poor performance status from bronchioloalveolar carcinoma (BAC), in whom a brief initial 5-week administration of gefitinib resulted in dramatic antitumor effects that lasted approximately 8.5 months after cessation of the treatment. Furthermore, the relapsed tumor later regressed again by re-treatment with the TKI. She survived 26 months since she first took gefitinib. Unexpectedly, neither sensitizing mutations for EGFR-TKIs nor increased copy numbers were detected in EGFR gene of her BAC cells. This case suggests that, in some patients with NSCLC, even short-term administration of gefitinib may bring about clinical benefits and disease response comparable to the standard long-term daily dosing schedule. Short-term use of gefitinib will also be able to minimize the expensive medical cost of the TKI. The potential role of short-term or pulse-dose therapy with EGFR-TKIs should be clarified in further prospective studies. Moreover, it is urgent to develop better strategies by which we could distinguish responders to the TKIs from nonresponders among patients who do not have any EGFR gene alterations.

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Publishing Authors By Initials

T Kijima,M Suzuki,K Ueda,S Minami,Y Takeda,S Goya,H Matsuoka,T Kumagai,M Yoshida,T Osaki,I Tachibana,S Yokota,I Kawase,T Kijima,M Suzuki,K Ueda,S Minami,Y Takeda,S Goya,H Matsuoka,T Kumagai,M Yoshida,T Osaki,I Tachibana,S Yokota,I Kawase,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Oncology research

VOLUME: 16

Page Numbers: 489-95

Journal Abbreviation: Oncol. Res.

ISSN: 0965-0407

DAY: 16

MONTH: 01

YEAR: 2007

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9208097

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.

AFFILIATION: Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. tkijima@imed3.med.osaka-u.ac.jp

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Oncol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report Related Publications

• ??herenkov phase-matched monochromatic THzwave generation using difference frequency generation with a lithium niobate crystal.
• A novel interpretation of closing volume based on single-breath nitrogen washout curve simulation.
• A novel synthesis of succinic acid type Gemini surfactant by the functional group interconversion of Corynomicolic acid.
• A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature.
• Application of Partial Least Square on Quantitative Analysis of L-, D-, and DL-Tartaric Acid by Terahertz Absorption Spectra.
• Basic study of a new soft resin applied with bisfunctional siloxane oligomer.
• Dumbbell-shaped intradiploic epidermoid cyst involving the dura mater and cerebellum.
• Enhancement of terahertz-wave output from LiNbO(3) optical parametric oscillators by cryogenic cooling.
• Enlarged entry space for the transpetrosal approach.
• Glomus jugulare tumor presenting with intracerebellar hemorrhage.
• Lipomatous meningioma.
• Measurements of particle number density using the variable-fringe-spacing laser Doppler velocimeter.
• Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung.
• Olfactory schwannoma.
• On the synthesis and structure of 4-hydroxy-3-phenyl-coumarins and related 2-imides.
• Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung Cancer.
• Phylogenetic analysis of the rDNA intergenic spacer subrepeats and its implication for the domestication history of foxtail millet, Setaria italica.
• Reduced size of the cochlear branch of the vestibulocochlear nerve in a child with sensorineural hearing loss.
• Short-term gefitinib treatment brought about a long-term regression of bronchioloalveolar carcinoma without EGFR gene alterations: a case report.
• Source analysis of the magnetic field evoked during self-paced finger movements.
• Successful multimodal treatment in a patient with thymoma accompanied by hepatic metastasis.
• Terahertz-wave generation in a conventional optical fiber.
• Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.
• [Genetic diagnoses and individualized treatment of gliomas]
• [Late result of nonvalved extracardiac conduit repair between venous ventricle and pulmonary artery]
• [Morbidity and mortality of coronary artery bypass surgery in patients 75 years of age or older]
• [Radial artery for coronary artery bypass graft]
• [Successful therapy with steroid and cyclophosphamide pulse for CNS lupus and lupus myelitis]
• [Survey on the birth rate and prognosis of infants with congenital heart disease]
• [Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer.]